Category: Cancer detection
-
Dr Guiping Wang appointed as a Junior Group Leader
Dr Guiping Wang joins the Cancer Research UK Cambridge Institute as a Junior Group Leader, starting in September 2026.
Find out more -
Shankar Balasubramanian receives the Princess of Asturias Award for Scientific and Technical Research
The 2026 award recognises Prof Balasubramanian and his co-recipients David Klenerman and Pascal Meyer for their pioneering work in genome sequencing technologies.
-
Prof Sir Steve Jackson receives the 2026 Galen Medal in Therapeutics
This award comes in recognition of his transformational work on the mechanisms of DNA repair, cell survival and the DNA-damage response (DDR), as well as for the development of the cancer-targeting drug Olaparib.
-
In Memoriam: Professor Greg Hannon (1964–2026)
It is with profound sadness that we share the news of the passing of Professor Greg Hannon, who led the Cancer Research UK Cambridge Institute for over eight years.
Find out more -
Most detailed map of breast tissue changes reveals role of menopause in cancer susceptibility
Scientists have created the most detailed map to date, comprising over 3 million cells, showing how breast tissue changes as women age – including dramatic changes during menopause.
-
Hannon Group joins global team to decode cancer’s dark proteome
Prof Greg Hannon and his group joins global Cancer Grand Challenges team taking on the dark proteome challenge.
Find out more -
1M to advance AI powered personalised ovarian cancer care
Researchers from our Brenton Group are part of an international team awarded the Global Ovarian Cancer Research Consortium’s inaugural AI Accelerator Grant.
Find out more -
Professor Sir Steve Jackson elected as a fellow of the American Association for Cancer Research
Senior Group Leader Sir Steve Jackson has been elected as a Fellow of the American Association for Cancer Research Academy in the Class of 2026.
Find out more -
New immune pathway offers treatment hope for childhood brain tumours
A newly discovered immune pathway could lead to gentler treatments for multiple childhood brain cancers, according to new research from our Gilbertson Group published today in Nature Genetics.
Find out more